In the field of interventional cardiology and radiology, the quality and properties of a coating technology determines how well drug-eluting balloons (DEBs) and drug-eluting stents (DES) can deliver anti-proliferative drugs from the surface of the device to the vessel wall.
Drug delivery must take place at the right moment and precisely at the right area of the arterial tissue with the recommended drug content. Here, a safe transfer is considered free of undesirable particulate generation from the coating matrix. Distribution and retention in arterial tissues are highly important and differ drastically between different DEB and DES devices. Eurocor’s coating technologies include only materials that have been approved for biomedical applications or are generally recognized as safe (GRAS) for drug delivery.
For us coating makes a big difference in the pursuit of the ideal DEB and DES device. Therefore, Eurocor continues to develop novel approaches to coating technologies, aiming to further optimize DEB and DES performance in challenging interventions and ultimately improving the patient’s quality of life.